Page 31 - Admaius 2023 ESGI report
P. 31
How we approach
Our Commitments Ou r S t r a t e gy Our Portfolio www.admaius.com
ESG and impact
Case study: New investment 2023
Parkville Pharmaceuticals
Sector Geography
Egypt
Our ESG and impact thesis for the business: SDG alignment
Our investment in the company aligns closely with our
Fund’s impact thesis, to support sustainable and innovative
Parkville is one of the largest and fastest growing businesses, that promote self-sufficiency and job creation
cosmeceutical companies in Egypt, employing in their local economies.
over 400 people, and manufacturing and Already employing over 400 people, the company’s new in-
distributing over 125 products across leading house manufacturing facility will further stimulate job creation
skincare, haircare and food supplement brands. including through the multiplier effect of a burgeoning
ecosystem of local suppliers and business partners supporting
Business Description the company’s operations.
Founded in 2008, Parkville manufactures high quality While the business already provides high quality, affordable
prescription-based skin care, haircare, food supplement and products to an 80% female customer base we see
muscle relaxant products, under several brands notably: further opportunities for innovation in developing the
StarVille, StrongVille, Bobai, Shaan, Enera, Seropipe, Super Kids, company’s brand portfolio towards products that better serve
and Sulfax. women’s needs.
The Company’s products are produced in a state-of-the-art
production facility in Alexandria and currently export to six
markets via a market leading, 240-person strong sales force.
Read more
30 Admaius Capital Partners ESG & Impact Report 2023